Dustin M McCraw
Overview
Explore the profile of Dustin M McCraw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCraw D, Myers M, Gulati N, Prabhakaran M, Brand J, Andrews S, et al.
PLoS Pathog
. 2023 Aug;
19(8):e1011514.
PMID: 37639457
Despite the availability of seasonal vaccines and antiviral medications, influenza virus continues to be a major health concern and pandemic threat due to the continually changing antigenic regions of the...
2.
Gulati N, Gallagher J, McCraw D, Harris A
Microsc Microanal
. 2019 Aug;
25(Suppl 2):1302-1303.
PMID: 31413663
No abstract available.
3.
McCraw D, Harris A
Microsc Microanal
. 2019 Mar;
23(Suppl 1):1322-1323.
PMID: 30846907
No abstract available.
4.
McCraw D, Gallagher J, Torian U, Myers M, Conlon M, Gulati N, et al.
Sci Rep
. 2018 Jul;
8(1):10342.
PMID: 29985483
Influenza virus continues to be a major health problem due to the continually changing immunodominant head regions of the major surface glycoprotein, hemagglutinin (HA). However, some emerging vaccine platforms designed...
5.
Gallagher J, McCraw D, Torian U, Gulati N, Myers M, Conlon M, et al.
Vaccines (Basel)
. 2018 May;
6(2).
PMID: 29799445
Influenza viruses affect millions of people worldwide on an annual basis. Although vaccines are available, influenza still causes significant human mortality and morbidity. Vaccines target the major influenza surface glycoprotein...
6.
Gallagher J, Torian U, McCraw D, Harris A
Virology
. 2017 Jan;
502:176-187.
PMID: 28061386
While nanoparticle vaccine technology is gaining interest due to the success of vaccines like those for the human papillomavirus that is based on viral capsid nanoparticles, little information is available...
7.
Gallagher J, Torian U, McCraw D, Harris A
J Struct Biol
. 2016 Dec;
197(3):294-307.
PMID: 28007449
Ribonucleoprotein (RNP) complexes of influenza viruses are composed of multiple copies of the viral nucleoprotein (NP) that can form filamentous supra-structures. RNPs package distinct viral genomic RNA segments of different...
8.
McCraw D, Gallagher J, Harris A
Clin Vaccine Immunol
. 2016 Apr;
23(6):483-495.
PMID: 27074939
Influenza virus afflicts millions of people worldwide on an annual basis. There is an ever-present risk that animal viruses will cross the species barrier to cause epidemics and pandemics resulting...
9.
McCraw D, ODonnell J, Taylor K, Stagg S, Chapman M
Virology
. 2012 Jun;
431(1-2):40-9.
PMID: 22682774
The use of adeno-associated virus (AAV) as a gene therapy vector is limited by the host neutralizing immune response. The cryo-electron microscopy (EM) structure at 8.5Å resolution is determined for...